Drug Profile
Oral therapeutics - Kamat Pharmatech
Latest Information Update: 28 Dec 2019
Price :
$50
*
At a glance
- Originator Kamat Pharmatech
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Dec 2019 No recent reports of development identified for clinical-Phase-Unknown development in Unspecified in USA (PO)
- 17 Nov 2016 Clinical trials in Undefined indication in USA (PO)